Mechanisms of Cancer-Related Fatigue
Top Cited Papers
Open Access
- 1 May 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 12 (S1), 22-34
- https://doi.org/10.1634/theoncologist.12-s1-22
Abstract
Cancer-related fatigue (CRF) is one of the most prevalent symptoms patients with cancer experience, both during and after treatment. CRF is pervasive and affects patients' quality of life considerably. It is important, therefore, to understand the underlying pathophysiology of CRF in order to develop useful strategies for prevention and treatment. At present, the etiology of CRF is poorly understood and the relative contributions of the neoplastic disease, various forms of cancer therapy, and comorbid conditions (e.g., anemia, cachexia, sleep disorders, depression) remain unclear. In any individual, the etiology of CRF probably involves the dysregulation of several physiological and biochemical systems. Mechanisms proposed as underlying CRF include 5-HT neurotransmitter dysregulation, vagal afferent activation, alterations in muscle and ATP metabolism, hypothalamic–pituitary–adrenal axis dysfunction, circadian rhythm disruption, and cytokine dysregulation. Currently, these hypotheses are largely based on evidence from other conditions in which fatigue is a characteristic, in particular chronic fatigue syndrome and exercise-induced fatigue. The mechanisms that lead to fatigue in these conditions provide a theoretical basis for future research into the complex etiology of this distressing and debilitating symptom. An understanding of relevant mechanisms may offer potential routes for its prevention and treatment in patients with cancer. Disclosure of potential conflicts of interest is found at the end of this article.Keywords
Funding Information
- Cephalon, Inc., Frazer, PA
This publication has 156 references indexed in Scilit:
- The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin TransportersNeuropsychopharmacology, 2006
- Fatigue in Women Receiving Adjuvant Chemotherapy for Breast CancerJournal of Pain and Symptom Management, 1999
- Effects of Branched-Chain Amino Acids and Carbohydrate on Fatigue During Intermittent, High-Intensity RunningInternational Journal of Sports Medicine, 1999
- Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndromeAnnals of Allergy, Asthma & Immunology, 1999
- Somnogenic and pyrogenic effects of interleukin-1β and lipopolysaccharide in intact and vagotomized ratsLife Sciences, 1998
- Effects of interferon-?, interleukin-1?, and tumor necrosis factor-? on the serotonin metabolism in the nucleus raphe dorsalis of the ratJournal of Neural Transmission, 1997
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997
- Rhythm alteration in patients with metastatic breast cancer and poor prognostic factorsZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancerJournal of Pain and Symptom Management, 1993
- Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent systemLife Sciences, 1983